Tear Duct OccluderTM is an FDA approved prescription device which is intended to temporarily occlude the nasolacrimal ducts in adult patients to help reduce outflow through the nasolacrimal ducts.
The primary users of this device would be glaucoma patients. For detail safety and prescribing information, see device patient labeling. Ask your doctor if Tear Duct OccluderTM is right for you.
U.S. Patent 8147467
Made in U.S.A.